N.B.: This evaluation refers to 2019 and is outdated: display the current evaluation.

BAYER AGCompany logo

Germany (DE)

OpenCorporation rating: 54.67 on 100

Ranking 2019: 25 on 568 companies

Primary and secondary NACE classification:
• Manufacture of pharmaceutical preparations (2120)
• Manufacture of plastics in primary forms (2016)

Company description

This German chemical and pharmaceutical company is engaged in the development and manufacture of pharmaceutical and medical products and health care products. Its products include: diagnostic equipment and pharmaceuticals, agricultural products such as crop protection and animal health, and specialty materials such as plastics and synthetic rubber. It was founded in 1863. It is headquartered in Leverkusen, Germany.The group operates under three major segments, Health care, Material Science and Crop science. Under Health care, the group researches, develops, manufactures and markets innovative products including Aspirin, which is one of the world's best-known pain-relievers, Ascensia, Kogenate, Adalat. Under Material Science, the group offers polycarbonate plastics, polyurethanes, coating raw materials and colorants. Brands include Makrolon, Baydur, Bayflex, Desmodur, Desmophen. Under Crop Sciences, the group offers crop protection and non-agricultural pest control products such as fungicides, herbicides, insecticides and seed treatment products. Its brands include Confidor, Gaucho, Admire, Merit, Folicur and Raxil.The company aims to have innovation and growth in the areas of health care, nutrition and high-tech materials by providing active substance in research, the consumer health business with the growth markets of Asia and new areas such as biotechnology and nanotechnology. It operates mainly in Europe, Asia-Pacific, Latin America and North America. The group is also active in Africa and Middle East.

[…] show more

OpenCorporation questionnaire

The read only version of the questionnaire submitted to this company is publicly available: view questionnaire.


The rating is calculated on the following metrics (for more information visit the section Methodology).

score (max is 100)
ratings 2018

HQ and subsidiaries

loading subsidiaries

* The position of map pins may not reflect the exact location

Latest news about bayer ag

9 March 2020 - 12:00

Investor Lawsuit Against Bayer Cites ‘Disastrous’ Monsanto Acquisition

A Bayer AG investor sued the board and other top company officials, claiming the “disastrous” 2018 acquisition of Monsanto Co. eroded the company’s share value by saddling it with potentially billions of dollars in liability from Roundup lawsuits.

About this evaluation

This company did not compile the OpenCorporation questionnaire, for this reason this evaluation was made only on data available to the project staff.

Claims and support from the company

If as a company manager or official of BAYER AG you want to enter in touch with our staff, provide more information to OpenCorporation or get an account to access and compile the company questionnaire, please write an email to support@opencorporation.org.

Tell the OpenCorporation team

If you detect corporate behavior in contrast with what emerges from the OpenCorporation corporate rating card in your country, or in the branch where you work, report it to info@opencorporation.org so that our team can take it in account.

More evaluations

This company has other evaluations:

Permament links

The link below will always open the 2019 evaluation:

2019: https://www.opencorporation.org/en/ranking/bayer-ag/2019    url copied

The link below will always open the latest evaluation available:

Last: https://www.opencorporation.org/en/ranking/bayer-ag/last    url copied